Evert Kueppers | CEO
BOOST Pharma ApS

Evert Kueppers, CEO, BOOST Pharma ApS

Evert Küppers is an all-rounded executive with over 25 years of operational experience in pharma & biotech with focus on Business & Corporate Development, Fundraising, and R&D Operations. As CEO, he led successfully cross-functional, international Management and R&D teams and closed multiple investment rounds with international, blue chip US/EU investors, as well as, private/public investors. For example, as CEO of Munich-based Pieris Pharmaceuticals (PIRS) he played a pivotal role in its R&D restructuring and subsequently refinancing led by US investor OrbiMed Advisors, which laid eventually the basis for its successful NASDAQ listing. Evert is an educated biomedical scientist (MSc., Leiden University, NL) and obtained an MBA degree from the RSM/Erasmus University, NL.

Appearances:



Day 1 - Wednesday 23 October @ 15:40

Children born with Osteogenesis Imperfecta: building health bones through cell therapy

last published: 13/Oct/24 14:15 GMT

back to speakers